Inogen delivered Q4 2025 revenue of $81.7 million, driven by strong international POC sales growth of 14.8%. While the company still reported a net loss, it showed significant year-over-year improvement in GAAP net loss, adjusted net loss, and adjusted EBITDA, supported by a strong debt-free balance sheet.

Inogen delivered strong second quarter 2025 financial results, with total revenue reaching $92.3 million, a 4.0% increase year-over-year. The company reported a GAAP net loss of $4.2 million but achieved positive adjusted EBITDA of $2.1 million for the second consecutive quarter. This performance led to an increase in full-year 2025 revenue guidance.

Inogen reported stronger financial results in the first quarter of 2025 compared to the prior year, driven by increased international and domestic business-to-business sales. This growth was partially offset by declines in direct-to-consumer sales and rental revenue. The company saw improvements in gross margin, operating expense, and net loss, and achieved positive adjusted EBITDA.

Inogen achieved significant growth in Q4 2024, with total revenue increasing by 5.5% to $80.1 million and a substantial improvement in gross margin to 45.3%. The company also significantly reduced its net loss and adjusted EBITDA loss compared to the prior year, indicating strong progress towards profitability.

Inogen reported a 5.8% increase in revenue to $88.8 million, driven by growth in the business-to-business channels. The company's gross margin improved to 46.5%, and operating expenses decreased due to a one-time goodwill impairment charge in the previous year. GAAP net loss was $6.0 million, with adjusted EBITDA at $0.5 million.

Inogen reported a 6.1% increase in total revenue to $88.8 million for Q2 2024, driven by international and domestic business-to-business sales. The company's GAAP net loss decreased to $5.6 million, and adjusted EBITDA was a positive $1.3 million.

Inogen reported an 8.1% increase in total revenue to $78.0 million for the first quarter of 2024, driven by higher international and domestic business-to-business sales. The company's GAAP net loss decreased to $14.6 million, and gross margin improved to 44.1%.

Inogen reported a Q4 2023 revenue of $75.9 million, a decrease compared to $88.1 million in Q4 2022. The GAAP net loss was $26.6 million, compared to a net loss of $56.6 million in the same quarter of the previous year.

Inogen reported a decrease in total revenue for the third quarter of 2023, with a net loss due to one-time non-cash impairment charges. The company is focusing on commercial strategy optimization and cost management.

Inogen reported a decrease in revenue by 19.1% to $83.6 million compared to the second quarter of 2022. The company experienced a GAAP net loss of $9.8 million and an adjusted EBITDA loss of $3.2 million. Inogen is focused on improving productivity, expanding its prescriber channel presence, and managing volatility in business-to-business channels.

Inogen's Q1 2023 revenue was $72.2 million, a 10.2% decrease compared to Q1 2022. However, rental revenue increased by 25.4%. The company reported a GAAP net loss of $20.3 million and is focused on returning to profitability.

Inogen reported a 15.3% increase in total revenue for Q4 2022, reaching $88.1 million. However, the company experienced a GAAP net loss of $56.6 million, primarily due to a one-time loss on disposal of intangible assets. Cash and cash equivalents stood at $187.0 million at the end of the year.

Inogen reported a 13.2% increase in revenue to $105.4 million compared to the third quarter of 2021. The increase was driven by higher domestic business-to-business sales and strength in the rental channel, offset by lower international business-to-business and direct-to-consumer sales. The company reported a GAAP net loss of $9.5 million and adjusted EBITDA was a loss of $1.2 million.

Inogen's Q2 2022 total revenue increased by 1.8% to $103.4 million compared to Q2 2021, driven by higher international sales and domestic rentals, but the company reported a GAAP net loss of $3.4 million.

Inogen reported a decrease in total revenue by 7.5% compared to Q1 2021, primarily due to supply chain constraints. However, the company saw growth in domestic direct-to-consumer revenue and international business-to-business revenue. The company reported a net loss of $14.2 million, or $0.62 per diluted share.

Inogen reported a 3.3% increase in total revenue for Q4 2021, reaching $76.4 million. The growth was driven by domestic direct-to-consumer sales and rental revenue, while international business-to-business sales also contributed positively. The company reported a net loss of $22.9 million, impacted by a non-cash income tax provision expense.

Inogen's total revenue for Q3 2021 increased by 25.3% to $93.1 million compared to the same period in 2020. The increase was primarily driven by sustained demand, improved average selling prices, and the reduced impact of the COVID-19 pandemic. The company reported a net income of $12.2 million, or $0.53 per diluted share.

Inogen's Q2 2021 financial results revealed a strong recovery and growth, with total revenue reaching a record $101.6 million, a 41.7% increase from Q2 2020. This growth was driven by strong consumer demand, improved average selling prices, and reduced COVID-19 impacts. The company reported net income of $5.1 million, or $0.22 per diluted share.

Inogen reported a slight decrease in total revenue for Q1 2021, with a net loss of $0.7 million. However, the company saw strong growth in rental revenue and sequential growth in all four sales channels.

Inogen reported a decrease in total revenue for Q4 2020, primarily due to the COVID-19 pandemic's impact on direct-to-consumer and international business-to-business sales channels. However, the company saw a rebound in domestic business-to-business sales and strong growth in rental revenue.

Inogen reported a decrease in total revenue by 19% compared to Q3 2019, primarily due to the COVID-19 pandemic, which led to reduced patient travel and activity outside the home, reduced consumer confidence, and physicians limiting patient interactions. However, the company saw sequential revenue growth from Q2 2020 and strong growth in rental revenue.

Inogen reported a decrease in total revenue by 29.1% compared to the same period in 2019, primarily due to the COVID-19 pandemic. Net income also decreased from $10.2 million to $2.6 million. However, rental revenue saw an increase of 16.9% due to higher revenue per patient and an increase in patients on service.

Inogen reported a slight decrease in total revenue for Q1 2020, with a net loss of $1.6 million. The company experienced growth in domestic and international business-to-business sales, but a decline in direct-to-consumer sales. Gross margins also decreased due to manufacturing inefficiencies and product sales mix. The company withdrew its 2020 guidance due to the uncertainty surrounding the impact of the COVID-19 pandemic.

Inogen reported a decline in total revenue for the fourth quarter of 2019, with decreases in direct-to-consumer, domestic business-to-business, and international business-to-business sales. The company experienced an operating loss and a net loss for the quarter, with a decrease in total gross margin. However, the company is maintaining its full year 2020 total revenue guidance.